ESMO 2024

13 - 17 September
Barcelona

Posters Presentation
Stay tuned for more information regarding our joint posters, covering multi-center real-world studies in growing the understanding of immune checkpoint inhibitors (ICIs) treatment in real-world cancer patients.

Unlock Insights in Immuno-Oncology
The comprehensive immuno-oncology datasets within LynxCare's European hospital network offer deep clinical insights into patients treated with Immune Checkpoint Inhibitors. By leveraging LynxCare's clinical NLP+AI technology,  up to 80% of clinical outcomes siloed and locked in clinical reports become accessible. This allows fresh perspectives on a.o. comorbidity factors, treatment patterns, adverse events (cardiotoxicity) and median overall survival. 

dataset insights_onco_immuno onco_1-Jan-29-2024-04-01-49-5397-PM

Let's Connect
Schedule a short introduction meeting with the LynxCare team onsite through the calendar below, and learn how we unlock medical data through NLP-AI with our network of hospitals in Europe. 

Meet the LynxCare Team onsite

Dries Hens

Dries Hens, M.D.
Chief Medical Officer, co-founder

Iege Bassez

Iege Bassez
Product Owner, Analytics Engineer

Clara Loeste

Clara L. Oeste
Senior Medical Writer